NDAOPHTHALMICSUSPENSION/DROPS
Approved
Jan 1972
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
FML (fluorometholone) by AbbVie is corticosteroid hormone receptor agonists [moa]. First approved in 1972.
Drug data last refreshed 8h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FML (fluorometholone) is a low-potency topical corticosteroid ophthalmic suspension approved in 1972 for treating ocular inflammation and allergic conjunctivitis. It works by binding to corticosteroid hormone receptors to suppress inflammatory responses in the eye. The drug is administered as eye drops for local anti-inflammatory effect.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), suggesting declining team size and strategic focus shift toward market maintenance rather than growth initiatives.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Pharmacologic Class:
Corticosteroid
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on FML offers limited career growth potential given its LOE-approaching status and zero linked job openings; roles available are primarily defensive/maintenance focused on protecting market share against generics. This is a stabilization role rather than a growth opportunity, suited for professionals seeking stability over expansion-driven careers.
Brand Manager
Worked on FML at AbbVie? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.